Bone Biologics Balance Sheet Health
Financial Health criteria checks 6/6
Bone Biologics has a total shareholder equity of $2.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.7M and $831.4K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.03m |
| Equity | US$2.91m |
| Total liabilities | US$831.40k |
| Total assets | US$3.74m |
Financial Position Analysis
Short Term Liabilities: BBLG's short term assets ($3.7M) exceed its short term liabilities ($831.4K).
Long Term Liabilities: BBLG has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BBLG is debt free.
Reducing Debt: BBLG currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BBLG has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BBLG is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.